Suppr超能文献

超声引导下透明质酸与酮咯酸关节腔内注射治疗拇指腕掌关节骨关节炎:一项回顾性对照研究

Ultrasound-guided intra-articular injection of hyaluronic acid and ketorolac for osteoarthritis of the carpometacarpal joint of the thumb: A retrospective comparative study.

作者信息

Koh Sung Hoon, Lee Sang Chul, Lee Woo Yong, Kim Jongwoo, Park Yongbum

机构信息

Department of Physical Medicine and Rehabilitation.

Department of Anesthesiology.

出版信息

Medicine (Baltimore). 2019 May;98(19):e15506. doi: 10.1097/MD.0000000000015506.

Abstract

Intra-articular hyaluronic acid (HA) is widely used to treat symptomatic osteoarthritis (OA) in the carpometacarpal joint (CMCJ) of the thumb. However, although apparently effective and relatively safe, intra-articular HA injections act relatively slowly. Therefore, a nonsteroidal anti-inflammatory drug could be added for more prompt pain relief. The aim of this study was to compare the efficacy and safety of ultrasound (US)-guided intra-articular injection of HA and ketorolac with that of HA alone in patients with OA of the CMCJ of the thumb.Seventy-four patients identified by chart review to have a diagnosis of OA of the CMCJ of the thumb received either a US-guided intra-articular injection of 0.5 mL of sodium hyaluronate and 0.5 mL of ketorolac (n = 38) or 0.5 mL of sodium hyaluronate and 0.5 mL of saline (n = 36). Disabilities of the arm, shoulder, and hand (DASH) and verbal numeric scale (VNS) pain scores were recorded before and 1, 3, and 6 months after injection. Univariable analyses (using the chi-squared test) and multiple logistic regression analysis were performed to evaluate the relationship between potential predictors of the outcome (treatment allocation, patient age and sex, duration of pain, and Eaton-Littler classification) and therapeutic effects.The DASH and VNS scores were improved at 1, 3, and 6 months postinjection in both groups. The onset of pain relief was significantly more rapid (at 1 month) after the injection containing HA and ketorolac than after the injection containing HA alone. In 55.3% of cases, pain and function were improved postinjection compared with baseline and remained so for up to 6 months. The success rate was not significantly different between the assessments at 1, 3, and 6 months, and the univariable analyses did not identify any statistically significant potential predictors of the outcome. Multiple logistic regression analysis did not identify any independent predictors of a successful outcome at midterm follow-up.The onset of analgesic action was more rapid after an injection containing HA and ketorolac than after 1 containing HA alone in patients with OA of the CMCJ of the thumb. There were no serious complications.

摘要

关节内注射透明质酸(HA)被广泛用于治疗拇指掌指关节(CMCJ)的症状性骨关节炎(OA)。然而,尽管关节内注射HA显然有效且相对安全,但其作用起效相对缓慢。因此,可以加用一种非甾体抗炎药以更快地缓解疼痛。本研究的目的是比较超声(US)引导下关节内注射HA和酮咯酸与单独注射HA对拇指CMCJ OA患者的疗效和安全性。通过病历审查确定74例诊断为拇指CMCJ OA的患者,接受了超声引导下关节内注射0.5 mL透明质酸钠和0.5 mL酮咯酸(n = 38)或0.5 mL透明质酸钠和0.5 mL生理盐水(n = 36)。在注射前以及注射后1、3和6个月记录手臂、肩部和手部功能障碍(DASH)和言语数字评分(VNS)疼痛评分。进行单变量分析(使用卡方检验)和多因素逻辑回归分析,以评估结果的潜在预测因素(治疗分配、患者年龄和性别、疼痛持续时间以及伊顿 - 利特勒分类)与治疗效果之间的关系。两组在注射后1、3和6个月时DASH和VNS评分均有所改善。含HA和酮咯酸的注射后疼痛缓解起效明显更快(在1个月时),比单独含HA的注射后更快。在55.3%的病例中,与基线相比,注射后疼痛和功能得到改善,并持续长达6个月。在1、3和6个月的评估中成功率无显著差异,单变量分析未发现任何具有统计学意义的结果潜在预测因素。多因素逻辑回归分析未发现中期随访成功结果的任何独立预测因素。对于拇指CMCJ OA患者,含HA和酮咯酸的注射后镇痛作用起效比单独含HA的注射后更快。未出现严重并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1918/6531173/cc8dc86c3333/medi-98-e15506-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验